TOP TIERMARKET NEWSWIRE
News & sentiment

ACUMEN PHARMACEUTICA (ABOS) — News & AI sentiment

ACUMEN PHARMACEUTICA (ABOS) news roundup. 3 stories aggregated over the last 30 days. Average 30-day sentiment is 61.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $90K — net selling of $90K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
3
avg sentiment 61.3/100
Insider net (90d)
$90K
0 buys · 2 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on ABOS

Jul 16
Jul 7
Jul 7
Jun 17
Jun 16
Jun 16
Jun 16
Jun 9
Jun 3
Acumen's Late-2026 Sabirnetug Readout Is A Viable Bet
Seeking Alpha63 · neutralproduct/pr
May 20
Open ABOS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →